Because of page limitations in CEN, we have decided to establish CEN Case Reports to facilitate publication of critical case reports and thereby contribute to clinical education. On behalf of the Japanese Society of Nephrology, we eagerly look forward to your submissions. Journal title: CEN Case Reports Published format: Electronic online edition only (separate orders for print edition accepted) Frequency of publication: twice a year (every 6 months) Contents: Case reports only Initial publication: May 2012 Submission and publication cost: No charge for three or fewer printed pages, including color pages Submission guidance: Use the online system Editorial Manager
starting 1 check details September 2011. For detailed instructions for submissions, please see the Instructions for Authors of CEN Case Reports.
http://www.springer.com/medicine/nephrology/journal/13730 [Inquiries] CEN Case Reports, Editorial Office c/o Springer Japan KK No. 2 Funato Bldg. 1-11-11 Kudan-kita, Chiyoda-ku, Tokyo 102-0073, Japan Tel.: +81-3-68317009 Fax: +81-3-68317010 E-mail: [email protected] CEN Case Reports Editor-in-Chief Kenjiro Kimura, MD Co-Editor-in-Chief Tatsuo Sakai, MD Deputy Editors Toshiki Moriyama, MD Shunya Uchida, MD”
“Erratum to: Clin Exp Nephrol (2011) 15:226–234 DOI 10.1007/s10157-010-0390-0 The correct name of the sixth author should be given as Yoshihiro Arimura, not Yasuhiro Arimura.”
“Introduction There has been no national registry of renal biopsies in Japan. The Committee for the Standardization of Renal Pathological Diagnosis and the Working Group for Renal Biopsy Database in the Japanese www.selleckchem.com/products/Staurosporine.html Society of Nephrology established the first nationwide, web-based, and prospective registry system, the Japan Renal Biopsy Registry (J-RBR), to record pathological, clinical, and laboratory data regarding all renal mafosfamide biopsies performed in 2007. To date, the epidemiological and clinical data of renal diseases are available from nationwide registries of renal biopsies from the United Kingdom [1], Italy [2],
Denmark [3], Spain [4], the Czech Republic [5], and Australia [6]. The role of a renal biopsy registry has been recently encouraged [7]. In Japan, several surveys were temporarily conducted for patients with restricted renal diseases, including primary glomerulonephritis [8], idiopathic membranous nephropathy (MN) [9], and immunoglobulin (Ig) A nephropathy (IgAN) [10]. However, there has been no web-based, nationwide, or prospective registry system of overall renal biopsies in Japan. The aim of the current study was to provide data to investigate the epidemiology and frequency of renal diseases with a histological diagnosis for patients registered in 2007 and 2008 on the J-RBR. Subjects and methods Registry system and patients The researchers on the Committee for the Standardization of Renal Pathological Diagnosis and the Working Group for Renal Biopsy Database in the Japanese Society of Nephrology participated in this study.
Related posts:
- There are now also enhanced endoscopic techniques, such as narrow
- 70,71 This high risk is similar to that seen with essential hyper
- Concentration was measured by Bradford assay, and proteins Separated by SDS-PAGE
- Information about each patient’s smoking status, including amount
- Important issues covered in this multidisciplinary clinic include